DE69623767D1 - Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus - Google Patents

Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus

Info

Publication number
DE69623767D1
DE69623767D1 DE69623767T DE69623767T DE69623767D1 DE 69623767 D1 DE69623767 D1 DE 69623767D1 DE 69623767 T DE69623767 T DE 69623767T DE 69623767 T DE69623767 T DE 69623767T DE 69623767 D1 DE69623767 D1 DE 69623767D1
Authority
DE
Germany
Prior art keywords
pct
alcoholism
pyrrolidine derivatives
treatment
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69623767T
Other languages
English (en)
Other versions
DE69623767T2 (de
Inventor
Assunta Imperato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE69623767D1 publication Critical patent/DE69623767D1/de
Application granted granted Critical
Publication of DE69623767T2 publication Critical patent/DE69623767T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE69623767T 1995-06-01 1996-05-29 Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus Expired - Lifetime DE69623767T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9506530A FR2734724B1 (fr) 1995-06-01 1995-06-01 Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme
PCT/FR1996/000801 WO1996038139A1 (fr) 1995-06-01 1996-05-29 Utilisation de derives de pyrrolidine au traitement de l'alcoolisme

Publications (2)

Publication Number Publication Date
DE69623767D1 true DE69623767D1 (de) 2002-10-24
DE69623767T2 DE69623767T2 (de) 2003-07-03

Family

ID=9479586

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69623767T Expired - Lifetime DE69623767T2 (de) 1995-06-01 1996-05-29 Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus

Country Status (27)

Country Link
US (1) US5935980A (de)
EP (1) EP0828486B1 (de)
JP (1) JPH11511747A (de)
KR (1) KR100424997B1 (de)
CN (1) CN1186432A (de)
AT (1) ATE224190T1 (de)
AU (1) AU711625B2 (de)
BG (1) BG63189B1 (de)
BR (1) BR9608633A (de)
CA (1) CA2219455C (de)
CZ (1) CZ289344B6 (de)
DE (1) DE69623767T2 (de)
DK (1) DK0828486T3 (de)
EA (1) EA000722B1 (de)
ES (1) ES2182987T3 (de)
FR (1) FR2734724B1 (de)
GE (1) GEP19991780B (de)
HU (1) HUP9900748A3 (de)
IL (1) IL118491A (de)
NO (1) NO975488L (de)
NZ (1) NZ310488A (de)
PT (1) PT828486E (de)
RO (1) RO117297B1 (de)
SK (1) SK282063B6 (de)
UA (1) UA58492C2 (de)
WO (1) WO1996038139A1 (de)
ZA (1) ZA964270B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744362B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
FR2744363B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
FR2744361B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
TW442449B (en) 1996-07-04 2001-06-23 Hoechst Ag Process for preparing 1,2-dichloroethane by direct chlorination
WO2002072582A1 (en) 2001-03-12 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine template libraries
US6869335B2 (en) 2002-07-08 2005-03-22 Micron Technology, Inc. Retaining rings, planarizing apparatuses including retaining rings, and methods for planarizing micro-device workpieces
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678938B1 (fr) * 1991-07-10 1993-10-08 Rhone Poulenc Rorer Sa Derives de pyrrolidine, leur preparation et les medicaments les contenant.
GB9203790D0 (en) * 1992-02-21 1992-04-08 Merck Sharp & Dohme Therapeutic agents
FR2700166B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.

Also Published As

Publication number Publication date
EA000722B1 (ru) 2000-02-28
ES2182987T3 (es) 2003-03-16
BG102087A (en) 1998-10-30
DK0828486T3 (da) 2003-01-27
DE69623767T2 (de) 2003-07-03
SK161197A3 (en) 1998-05-06
CA2219455C (fr) 2009-02-24
BG63189B1 (bg) 2001-06-29
FR2734724A1 (fr) 1996-12-06
UA58492C2 (uk) 2003-08-15
IL118491A0 (en) 1996-09-12
NZ310488A (en) 2000-07-28
NO975488L (no) 1998-01-19
HUP9900748A3 (en) 2000-01-28
PT828486E (pt) 2002-12-31
CZ289344B6 (cs) 2002-01-16
MX9708875A (es) 1998-03-31
KR19990021859A (ko) 1999-03-25
AU711625B2 (en) 1999-10-21
KR100424997B1 (ko) 2004-06-23
ZA964270B (en) 1996-08-26
EP0828486A1 (de) 1998-03-18
SK282063B6 (sk) 2001-10-08
AU6129096A (en) 1996-12-18
WO1996038139A1 (fr) 1996-12-05
HUP9900748A1 (hu) 1999-07-28
EA199700439A1 (ru) 1998-08-27
IL118491A (en) 2002-05-23
CA2219455A1 (fr) 1996-12-05
EP0828486B1 (de) 2002-09-18
FR2734724B1 (fr) 1997-07-04
CN1186432A (zh) 1998-07-01
ATE224190T1 (de) 2002-10-15
NO975488D0 (no) 1997-11-28
CZ378597A3 (cs) 1998-03-18
RO117297B1 (ro) 2002-01-30
GEP19991780B (en) 1999-10-05
BR9608633A (pt) 1999-02-02
US5935980A (en) 1999-08-10
JPH11511747A (ja) 1999-10-12

Similar Documents

Publication Publication Date Title
DE69815090D1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
ATE207356T1 (de) Verwendung von tiagabin zur behandlung von schlafstörungen
DE69512930T2 (de) Stilben-derivate verwendbar als cyclooxygenase-2 hemmer
DE69634900D1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
DE69528475D1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE69623767D1 (de) Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus
DE59109225D1 (de) Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
ATE203162T1 (de) Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4- aza-5 alpha-androst-1-en-3-one
DE60033569D1 (de) Neue verwendung von prodigiosin zur behandlung von diabetes mellitus
DE69429013D1 (de) Verwendung von dimeticon zur behandlung der konstipation
DE69711422D1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC